A MAMMOTH RAISE: BEN LAMM'S $225 MILLION RAISE

Summary from the TLDR Founders newsletter

Colossal Biosciences aims to bring extinct species like the woolly mammoth back to life using advanced genetic technologies. Unlike traditional startups focused on rapid returns, Colossal requires patient investors who understand the broader implications of its groundbreaking work, which has applications in healthcare, national security, and conservation. Despite raising $225 million, the company faces challenges in balancing its ambitious goals with the need to support current conservation efforts, while also fostering new technological advancements that could benefit global biodiversity.